1. Cohen RM, Kleinstein SH, Louzoun Y. Somatic hypermutation targeting is influenced by location within the immunoglobulin V region. Mol Immunol. 2011; 48:1477–1483.
![crossref](/image/icon/bnr_ref_cross.gif)
2. Balint RF, Larrick JW. Antibody engineering by parsimonious mutagenesis. Gene. 1993; 137:109–118.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Barbas CF 3rd, Burton DR. Selection and evolution of high-affinity human anti-viral antibodies. Trends Biotechnol. 1996; 14:230–234.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Haidar JN, Yuan QA, Zeng L, Snavely M, Luna X, Zhang H, Zhu W, Ludwig DL, Zhu Z. A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach. Proteins. 2012; 80:896–912.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Wu L, Oficjalska K, Lambert M, Fennell BJ, Darmanin-Sheehan A, Ní Shúilleabháin D, Autin B, Cummins E, Tchistiakova L, Bloom L, et al. Fundamental characteristics of the immunoglobulin VH repertoire of chickens in comparison with those of humans, mice, and camelids. J Immunol. 2012; 188:322–333.
![crossref](/image/icon/bnr_ref_cross.gif)
6. Barbas CF. Phage Display: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press;2001.
7. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of Proteins of Immunological Interest. 5th ed. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health;1991.
8. Kim HY, Tsai S, Lo SC, Wear DJ, Izadjoo MJ. Production and characterization of chimeric monoclonal antibodies against Burkholderia pseudomallei and B. mallei using the DHFR expression system. PLoS One. 2011; 6:e19867.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Tsurushita N, Park M, Pakabunto K, Ong K, Avdalovic A, Fu H, Jia A, Vásquez M, Kumar S. Humanization of a chicken anti-IL-12 monoclonal antibody. J Immunol Methods. 2004; 295:9–19.
![crossref](/image/icon/bnr_ref_cross.gif)
10. Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Scielzo C, Laoutaris N, Karlsson K, Baran-Marzsak F, Tsaftaris A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 2008; 111:1524–1533.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Wiens GD, Heldwein KA, Stenzel-Poore MP, Rittenberg MB. Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion. J Immunol. 1997; 159:1293–1302.
12. Wagner SD, Milstein C, Neuberger MS. Codon bias targets mutation. Nature. 1995; 376:732.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Shapiro GS, Aviszus K, Ikle D, Wysocki LJ. Predicting regional mutability in antibody V genes based solely on di- and trinucleotide sequence composition. J Immunol. 1999; 163:259–268.
14. Yang J, Jia Z, Xiang J. Substitution of surface-exposed framework residues alters secretion of recombinant fusion protein Fv/tumor necrosis factor in
Escherichia coli
. IUBMB Life. 1999; 48:327–332.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Rodríguez-Rodríguez ER, Ledezma-Candanoza LM, Contreras-Ferrat LG, Olamendi-Portugal T, Possani LD, Becerril B, Riaño-Umbarila L. A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody. J Mol Biol. 2012; 423:337–350.
![crossref](/image/icon/bnr_ref_cross.gif)
16. Tanha J, Nguyen TD, Ng A, Ryan S, Ni F, Mackenzie R. Improving solubility and refolding efficiency of human V(H)s by a novel mutational approach. Protein Eng Des Sel. 2006; 19:503–509.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Tangri S. LiCalsi C, Sidney J, Sette A. Rationally engineered proteins or antibodies with absent or reduced immunogenicity. Curr Med Chem. 2002; 9:2191–2199.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Shih HH, Tu C, Cao W, Klein A, Ramsey R, Fennell BJ, Lambert M, Ní Shúilleabháin D, Autin B, Kouranova E, et al. An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognition. J Biol Chem. 2012; 287:44425–44434.
![crossref](/image/icon/bnr_ref_cross.gif)